JNCCN
More than 25,000 oncologists and other cancer care professionals across the United States read JNCCN—Journal of the National Comprehensive Cancer Network. This peer-reviewed, indexed medical journal provides the latest information about best clinical practices, oncology health services research, and translational medicine. JNCCN features updates on the NCCN Clinical Practice Guidelines in Oncology® (NCCN Guidelines®), solicited review articles elaborating on guideline recommendations, health services research, and case reports highlighting molecular insights in patient care.
JNCCN's vision is to further the mission of NCCN by serving as the primary resource for information on NCCN Guidelines®, innovation in translational medicine, and on scientific studies related to oncology health services research, including quality care and value, bioethics, comparative and cost effectiveness, public policy, and interventional research on supportive care and survivorship.
JNCCN is indexed by MEDLINE/PubMed, Chemical Abstracts, Embase, EmCare, and Scopus.
The 2023 Impact Factor for JNCCN is 14.8.*
JNCCN is dedicated to improving the quality of cancer care locally, nationally, and internationally while enhancing the collaboration between academic medicine and the community physician. JNCCN is further committed to disseminating information across the cancer care continuum by publishing clinical practice guidelines and guidelines insights, and reporting rigorous health services research.
JNCCN also provides a forum for correspondence and commentary.
JNCCN
Editor-in-Chief
| Daniel M. Geynisman, MD |
Editorial
| Senior Director Kimberly A. Callan, MS, ELS |
Senior Associate Managing Editor Kerrin M. Rosenthal, MA |
| Senior Journal Production Specialist Genevieve Emberger Hartzman, MA |
*InCites™ Journal Citation Report
